Blood biomarkers in dynamic prediction of conversion to Alzheimer's disease: An application of joint modeling.

Plasma p-tau181 and NfL could serve as biomarkers for the prediction of AD onset, and the individualized prediction opens up the possibility to provide clinical information at a personal level.